Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspective on cervical cancer: why prevent?

C P Morrow1, W Cozen

  • 1Division of Gynecologic Oncology, Women's and Children's Hospital, University of Southern California School of Medicine, Los Angeles 90033, USA.

Journal of Cellular Biochemistry. Supplement
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The CODATwins Project: The Current Status and Recent Findings of COllaborative Project of Development of Anthropometrical Measures in Twins.

Twin research and human genetics : the official journal of the International Society for Twin Studies·2019
Same author

The role of HLA variation in lymphoma aetiology and survival.

Journal of internal medicine·2019
Same author

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Nature communications·2014
Same author

Genetic burden in multiple sclerosis families.

Genes and immunity·2013
Same author

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics.

Blood cancer journal·2013
Same author

Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Cervical cancer screening using cervical cytology significantly reduces mortality rates by detecting precursor lesions and early-stage invasive cancer. Despite high costs and numerous false positives, comprehensive screening programs prove effective in lowering cervical carcinoma deaths.

Area of Science:

  • Oncology
  • Public Health
  • Gynecology

Background:

  • Cervical carcinoma (CC) remains a global health concern, particularly for women worldwide, despite declining mortality in some regions.
  • Incidence rates vary significantly globally, with higher risks observed in countries like Peru compared to the U.S. and Israel.
  • A concerning trend of increased CC mortality among younger women (<35 years) has been reported in industrialized nations.

Purpose of the Study:

  • To review the impact of cervical cytology screening on cervical carcinoma incidence and mortality.
  • To discuss the challenges and effectiveness of screening for precursor lesions and early-stage CC.
  • To briefly examine the societal impact of CC and explore alternative early diagnosis and prevention strategies.

Main Methods:

Related Experiment Videos

  • Review of epidemiological data on cervical carcinoma incidence and mortality rates.
  • Analysis of the role and effectiveness of cervical cytology screening programs.
  • Discussion of the management of precursor lesions and the implications for healthcare systems.

    • Main Results:

    • Cervical cytology screening, when comprehensive and repetitive, can reduce CC mortality by up to 80%.
    • Most CC cases occur in patients who do not comply with screening recommendations.
    • Screening detects precursor lesions, leading to a higher rate of abnormal results and interventions than invasive CC itself.

    Conclusions:

    • Cervical cytology is the primary strategy for reducing CC incidence and mortality.
    • Effective screening relies on early detection of invasive cancer and treatment of precursor lesions, preventing progression.
    • While costly, the benefits of reduced mortality and improved patient outcomes justify comprehensive screening programs.